Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GammaGA: Study of the Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma

NCT05992532 is registered in ClinicalTrials.gov with Fundación Española de Hematología y Hemoterapía as lead sponsor.

NCT NCT05992532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05992532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GammaGA: Study of the Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Lead sponsor
Fundación Española de Hematología y Hemoterapía
Phase
Observational
Overall status
Recruiting
Start date
May 30, 2023
Completion date
May 31, 2026
Enrollment
210 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acid sphingomyelinase deficiency, gaucher disease